Pure Global
NCT05908578

Exercise Frequency During Endurance Training: Cardiorespiratory, Hematological, and Muscle Oxidative Adaptations

University of Calgary·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Exercise Training
Drug/Device/Intervention
High Frequency Exercise Training
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University of Calgary
Location
Calgary, Canada
Timeline & enrollment
Phase
N/A
Start date
May 22, 2023
End date
Aug 01, 2024
Enrollment
32 participants
Primary outcome

Change from baseline maximal oxygen uptake (VO2max) after 8 weeks of training

Summary

The goal of this interventional study is to compare training for different numbers of days
 each week in healthy, young individuals. The main questions it aims to answer are:
 
 - Does exercising less often improve endurance fitness as much as exercising more often?
 
 - Are endurance fitness improvements caused by improvements in the muscle and blood?
 
 Participants will train on a stationary bike for eight weeks. Researchers will measure the
 participants endurance fitness, as well as muscle and blood characteristics, before and after
 training to look for improvements from the training protocols.
 
 Researchers will compare low-frequency exercise (two times per week) and high-frequency
 exercise (four times per week) to see if they each improve endurance fitness.

ICD-10 classifications
Orthoptic trainingLack of physical exerciseOther physical therapyCardiac rehabilitationExhaustion due to excessive exertion
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05908578
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05908578 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Calgary and is currently Recruiting. The study focuses on Exercise Training. Target enrollment is 32 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.